Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances

SIMPLE SUMMARY: Patients with unresectable hepatocellular carcinoma (HCC), the most common primary tumor of the liver, have poor prognosis and are increasing worldwide. The recent approval of several novel therapies for HCC was long expected, and it will make physician decision-making more challengi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cucarull, Blanca, Tutusaus, Anna, Rider, Patricia, Hernáez-Alsina, Tania, Cuño, Carlos, García de Frutos, Pablo, Colell, Anna, Marí, Montserrat, Morales, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833604/
https://www.ncbi.nlm.nih.gov/pubmed/35158892
http://dx.doi.org/10.3390/cancers14030621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833604/
https://www.ncbi.nlm.nih.gov/pubmed/35158892
http://dx.doi.org/10.3390/cancers14030621

Ejemplares similares